ロード中...
Treatment adherence in tyrosinemia type 1 patients
BACKGROUND: While therapeutic advances have significantly improved the prognosis of patients with hereditary tyrosinemia type 1 (HT1), adherence to dietary and pharmacological treatments is essential for an optimal clinical outcome. Poor treatment adherence is well documented among patients with chr...
保存先:
| 出版年: | Orphanet J Rare Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173906/ https://ncbi.nlm.nih.gov/pubmed/34082789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01879-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|